Antimalarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q4
Anti-malarial drug use by pregnant women: Percentage of women with a live birth in the two years preceding the survey who during the pregnancy took any antimalarial drug for prevention, and who took SP/Fansidar two or more doses.